Doctors advise most patients on GLP-1 obesity drugs such as Wegovy and Zepbound to stay on them to keep the weight off, but ...

Weight-loss drugs significantly improve health, though they’re also tied to increased spending on other medical care that’s ...

Eli Lilly is one step closer to bringing an oral weight loss medicine to the booming obesity drug market. A clinical trial ...

Swiss generic drug manufacturer Sandoz plans to launch unbranded weight-loss drugs in Canada at discounts of up to 70% compared to branded versions once patents begin to expire next year, CEO Richard ...

More than half of large employers plan to scale back health care benefits next year as rising costs from weight-loss and specialty drugs squeeze budgets, according to a new survey released by ...

Blockbuster weight loss drugs like Wegovy and Zepbound have surged in popularity, but high prices have left them out of reach for many obese Americans.

Cigna has sold its Medicare businesses and slashed the number of people it covers in its ACA plans by more than half.

How to find out if weight loss drugs are covered by your insurance, and what to do if they're not Ozempic (semaglutide), Victoza (liraglutide), and Wegovy (semaglutide) are popular medications ...

The report, compiled for The New York Times by health analytics company Komodo Health, shows that denial rates rose from 18.3% to 22.9%. The rejections went up across many major health plans, ...

Insurance coverage for GLP-1 agonists when used for weight loss varies widely, explains GoodRX, a platform for medication savings. But these medications are often covered when prescribed for their ...

rising prices are forcing a rethink: "Some employers facing big cost increases in 2026 may feel this coverage is out of reach," Fluno said. Greater competition in the weight-loss drug market in coming ...